Goldman Sachs analyst expects positive updates from Vertex's first Investor Day as a public company on March 19, reiterates ...
Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...
Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.
Nvidia (NVDA) CEO Jensen Huang took to the stage Tuesday afternoon to deliver his keynote speech at the chip giant's 2025 GTC event (GPU Technology Conference), where he previewed the company's ...
Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...
DJ Dave is a household name harking back to the 1980s and ’90s, and he believes his popularity stems from his songs that are centred around unity. He said he achieved popularity in the country ...
After hours: March 21 at 7:13:50 PM EDT Loading Chart for VRTX ...
Minister Ofir Sofer and opposition MK Gadi Eisenkot, whose offices neighbor each other, presented each other with Purim gifts. 'I wish the good relations between us would be the same between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback